Replimune Group, Inc. (REPL)
$14.77+5.12%Close
BUYRECOVERY · day 16
Key stats
Short interest · FINRA settlement 2026-07-31
52-week IV5.1%–499.5%
- Market cap
- $1.2B
- Avg volume
- 6.6M
- Beta
- 0.90
- P/E (TTM)
- -4.69
- IV-%ile
- 4
- IV ATM
- 62.7%
- Short % float
- 35.52%
- Days to cover
- 3.3
- SI change
- +16.4%
- 1W
- -1.34%
- 1M
- +41.20%
- 3M
- +182.95%
- YTD
- +65.96%
- vs SPY 1W
- +0.03%
- vs SPY 1M
- +37.47%
- vs SPY 3M
- +179.85%
- vs SPY YTD
- +53.87%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- CODXSELLCo-Diagnostics, Inc.CRISISQ -7$1.21+5.22%
- SGRYSELLSurgery Partners, Inc.CRISISQ 7$14.52+4.16%
- LXEOBUYLexeo Therapeutics, Inc. Common StockRECOVERYQ -3$4.88-3.56%
- RGCSELLRegencell Bioscience Holdings LimitedCRISISQ 37$5.30-2.57%
- GYREBUYGyre Therapeutics, Inc.RECOVERYQ -2$6.91-1.57%
- BJDXSELLBluejay Diagnostics, Inc.CRISISQ -30$0.91-3.19%
- ENGNSELLenGene Holdings Inc.RECOVERYQ -5$1.78+0.56%
- NTHIBUYNeonc Technologies Holdings, Inc.RECOVERYQ -14$4.68+2.63%
- ABVCSELLABVC BioPharma, Inc.CRISISQ -6$0.89+0.00%
- ALMSSELLAlumis Inc. Common StockCRISISQ 33$24.17+5.73%
- RXSTBUYRxSight, Inc.CRISISQ -10$6.25+2.63%
- VANIBUYVivani Medical, Inc.RECOVERYQ -7$1.38-2.13%
Industry peers
FMP comparable companies · ranked by market cap
- IOVABUYIovance Biotherapeutics, Inc.$4.0BRECOVERYQ 7$8.99-7.79%
- MBXBUYMBX Biosciences, Inc. Common Stock$3.2BRECOVERYQ 45$66.35-0.03%
- VIRBUYVir Biotechnology, Inc.$1.6BRECOVERYQ 12$9.21+6.19%
- AVBPSELLArriVent BioPharma, Inc.$1.4BRECOVERYQ 23$29.18-0.21%
- MGTXBUYMeiraGTx Holdings plc$1.3BBULLQ 9$14.54-1.38%
- ATXSAstria Therapeutics, Inc.$718M$12.58
- VALNBUYValneva SE$647MRECOVERYQ 1$6.82+2.05%
- PRMESELLPrime Medicine, Inc.$585MRECOVERYQ -8$3.24+4.63%
- ARVNBUYArvinas, Inc.$582MRECOVERYQ 10$9.03+3.77%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 2
- VALUE
- 0
- GROWTH
- 46
- GARP
- 4
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-95.6%
REV YoY-
ROE-134.3%
EPS YoY-
ROA-117.7%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-4.69
P/E FWD-
SECTOR PE22.60
INDUSTRY PE17.46
P/B13.54
P/FCF-
EV/EBITDA-3.72
EV/EBIT-
PEG-
FCF YIELD-22.61%
BUYBACK0.00%
RISK
INT COV-31.5×
D/E26.37
ALTMAN Z-5.44
CURR RATIO5.23
ND/EBITDA-
BETA0.90
INTEREST COVERAGE < 1.5X (-31.46X)NET INCOME (TTM) < 0
